MILESTONE PHARMACEUTICALS IN (MIST) Earnings History & Surprises

NASDAQ:MIST • CA59935V1076

Current stock price

1.04 USD
-0.11 (-9.57%)
At close:
1.04 USD
0 (0%)
After Hours:

MIST Earnings overview

Past quarterly earnings results for MILESTONE PHARMACEUTICALS IN (MIST), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
$0.09
Revenue Estimate
38.291M

Last Reported

Most Recent
Release Date
Mar 20, 2026
Period
Q4 / 2025
EPS Reported
-$0.18
EPS Surprise
-10.29%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
25%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.18 -0.16 -10.29% 9.55% 1.546M - -
Q3 2025 -0.12 -0.17 28.26% 14.29% - -
Q2 2025 -0.20 -0.18 -10.47% -42.86% - -
Q1 2025 -0.31 -0.19 -64.28% -47.62% - -
Q4 2024 -0.20 -0.16 -27.93% 37.81% - -
Q3 2024 -0.14 -0.17 15.96% 60.00% - -
Q2 2024 -0.14 -0.19 27.76% 62.16% - -
Q1 2024 -0.21 -0.27 20.81% 40.00% - -100.00%
Q4 2023 -0.32 -0.32 -0.39% -3.23% - -100.00%
Q3 2023 -0.35 -0.39 10.17% -2.94% - -100.00%
Q2 2023 -0.37 -0.39 6.02% 5.13% - -
Q1 2023 -0.35 -0.41 13.78% -6.06% 1M - -
Q4 2022 -0.31 -0.34 9.28% 22.50% 3.5M 892.5K 292.16% -
Q3 2022 -0.34 -0.42 18.30% - 1.5M - -
Q2 2022 -0.39 -0.37 -6.21% -2,050.00% - -100.00%
Q1 2022 -0.33 -0.40 17.04% -10.00% - -
Q4 2021 -0.40 -0.37 -7.74% -207.69% - -
Q3 2021 -0.34 -0.39 13.19% 15.00% - -
Q2 2021 0.02 -0.27 107.48% 103.77% 15M 3.06M 390.20% -
Q1 2021 -0.30 -0.33 10.33% 55.22% - -
Q4 2020 -0.13 -0.41 68.61% - - -
Q3 2020 -0.40 -0.50 19.97% - - -
Q2 2020 -0.53 -0.48 -11.15% - - -
Q1 2020 -0.67 -0.76 11.53% - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

MIST EPS Q2Q GrowthMIST EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 -500 -1K -1.5K -2K

Revenue Historical Q2Q growth and Acceleration

MIST Revenue Q2Q GrowthMIST Revenue Q2Q GrowthRevenue Q2Q Growth Q2/22 Q3/23 Q4/23 Q1/24 Q4/26 Q1/27 Q2/27 Q3/27 Q4/27 0 100 200 300 400

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
1
Average EPS beat (4)
-14.19%
Max EPS beat (4)
28.26%
Min EPS beat (4)
-64.28%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, MIST has beaten EPS estimates in 1 out of 4 releases
In the last 4 quarters, MIST reported -14.2% below the EPS estimates on average.
MIST Overview MIST Technical Analysis Report MIST Fundamental Analysis Report MIST Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

MILESTONE PHARMACEUTICALS IN / MIST Earnings FAQ

When did MILESTONE PHARMACEUTICALS IN (MIST) report earnings last quarter?

MILESTONE PHARMACEUTICALS IN (MIST) last reported earnings on 3/20/2026.

Can you provide information on whether MILESTONE PHARMACEUTICALS IN beat earnings estimates in the last quarter?

MILESTONE PHARMACEUTICALS IN (MIST) missed EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does MIST stock beat earnings estimates?

In the last 4 quarters, MILESTONE PHARMACEUTICALS IN (MIST) has beaten EPS estimates in 1 out of 4 releases.